InMed to test INM-750 in vitro, estimates clinical trials for 2018-2020 ATERA SAS to develop 3D skin models to help pre-clinical tests of INM-750 INM-750 being developed to treat skin disease epidermolysis bullosa, with a successful therapy having potential global market of $1 billion InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a biopharmaceutical company focused […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.